Search results for "Roth"
showing 10 items of 806 documents
An Interview with the Brother, Micheál Ó Nualláin
2015
This interview with Micheál Ó Nualláin, Brian O’Nolan’s brother and the only surviving member of his generation of the family, was conducted on 10 June 2014 in Monkstown, County Dublin. Its purpose was to obtain information about Brian O’Nolan’s private library at the John J. Burns Library, Boston College; the archive being the focal point of this issue of The Parish Review. It was Micheál who sold the last of his brother’s effects to Boston College in May 1997 and therefore he is in a position to answer questions about the purchase of the library, its contents and their provenance, and the reading practices of Brian and Evelyn O’Nolan.To read the article, click Download or View PDF.
Hydrothermal synthesis of zeolites from rhyolitic pumice of different geological origins
1983
Abstract Twelve samples of rhyolitic pumice from widely different origins were subjected to zeolitization in standard hydrothermal conditions (solid/liquid ratio, 1 5 ; T , 95°C; reaction time, 5 h; alkaline solution 5 N NaOH). The Si Al ratio of the starting material was of special importance in that zeolites formed with Si Al ratios similar to or smaller than that of the parent material. Pumice with low SiO 2 Al 2 O 3 , and high Fe content, preferentially gave rise to zeolites with lower SiO 2 Al 2 O 3 ratio than in the case of lower Fe and higher SiO 2 Al 2 O 3 ratio.
“In States Unborn and Accents Yet Unknown”: Spectral Shakespeare in Paolo and Vittorio Taviani’s Cesare deve morire (Caesar Must Die).
2014
The paper focuses on Paolo and Vittorio Taviani’s Cesare deve morire (Caesar Must Die) (2012), an Italian adaptation of Julius Caesar set in a high security prison in Rome with a cast entirely made of convicts or former convicts. It explores how this adaptation "deconstructs" and "rewrites" Shakespeare (from an "Interview" with the film directors), especially by setting Julius Caesar in the "unborn state" of a prison, and through the use of a number of "accents yet unknown"–the inclusion of "dialects" from the South of Italy that not only displace the English "original" but also "standard" Italian translations of the play. The paper argues that the "Shakespeare" that emerges from this film …
Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis
2003
Abstract Background & aims: Emergency sclerotherapy is used as a first-line therapy for variceal bleeding in cirrhosis, although pharmacologic treatment stops bleeding in most patients. We performed a meta-analysis comparing emergency sclerotherapy with pharmacologic treatment. Methods: MEDLINE (1968–2002), EMBASE (1986–2002), and the Cochrane Library (2002;4) were searched to retrieve randomized controlled trials comparing sclerotherapy with vasopressin (± nitroglycerin), terlipressin, somatostatin, or octreotide for variceal bleeding in cirrhosis. Outcome measures were failure to control bleeding, rebleeding, blood transfusions, adverse events, and mortality. Results: Fifteen trials were …
Survival and prognostic indicators in compensated and decompensated cirrhosis
1986
Six-year survival of cirrhosis was assessed in a series of 1155 consecutive patients (751 men, 404 women). Among the men, 33% were alcoholics and 18% were HBsAg positive; corresponding figures for the women were 15% and 6%, respectively. Features of decompensation at first presentation were observed in 63% of the patients. Six-year survival was 54% in compensated and 21% in decompensated patients. No significant differences in survival were found between alcoholics and nonalcoholics. Leading causes of death were liver failure (49%), hepatocellular carcinoma (22%), and bleeding (13%). The prognostic role of 21 variables was evaluated separately in compensated and decompensated patients by th…
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study
2018
OBJECTIVES: Thrombocytopenia is a hallmark for patients with cirrhosis and it is perceived as a risk factor for bleeding events. However, the relationship between platelet count and bleeding is still unclear. METHODS: We investigated the relationship between platelet count and major or clinical relevant nonmajor bleedings during a follow-up of â¼4 years. RESULTS: A total of 280 cirrhotic patients with different degrees of liver disease (67% males; age 64±37 years; 47% ChildâPugh B and C) were followed up for a median of 1,129 (interquartile range: 800â1,498) days yielding 953.12 patient-year of observation. The annual rate of any significant bleeding was 5.45%/year (3.57%/year and 1.8…
TIPS for Prevention of Recurrent Bleeding in Patients with Cirrhosis: Meta-analysis of Randomized Clinical Trials
1999
To compare the effects of transjugular intrahepatic portosystemic shunt (TIPS) creation with those of endoscopic treatment with or without propranolol administration (i.e, conventional treatment) on recurrent bleeding, encephalopathy, and mortality by using meta-analysis of 11 published randomized clinical trials.Data from 11 relevant studies were retrieved by means of computerized and manual search. The combinability of the studies was assessed in terms of clinical and statistical criteria. Data were extracted on the basis of the intention-to-treat principle, and treatment effects were measured as risk differences between TIPS creation and conventional treatment. Pooled estimates were comp…
Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.
1998
beta-Blockers and sclerotherapy prevent long-term upper digestive rebleeding in cirrhosis but they seem ineffective for early rebleeding. We compared octreotide with a placebo for the prevention of early rebleeding in cirrhotic patients. After control of acute upper digestive bleeding, 262 consecutive cirrhotic patients were randomized to octreotide 100 microgram subcutaneously three times a day for 15 days (n = 131) or to the placebo (n = 131), in a double blind pragmatic trial in which beta-blockers and/or sclerotherapy were allowed together with the experimental treatment. Separate randomization and analysis were performed according to whether patients were eligible for beta-blockers and…
Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort s…
2000
Abstract Background. Although band ligation is now recommended for prevention of rebleeding from oesophageal varices in cirrhosis, sclerotherapy is still widely used. Patients submitted to chronic sclerotherapy undergo several endoscopies and experience a large number of serious complications. However, long-term outcome is poorly defined. Aims. To assess the clinical course and prognostic indicators of patients undergoing chronic sclerotherapy for prevention of variceal rebleeding as a basis for future evaluation of long-term band ligation outcome. Methods. Prospective cohort study prognostic analysis by the Cox proportional hazards model. Results. A total of 218 consecutive cirrhotic patie…
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms
2005
Abstract Background. Prothrombin time is a benchmark for functional assessment in cirrhosis and Factor VII levels (FVII), crucial in determining the prothrombin time, are genetically determined. Methods. We have evaluated the prothrombin time, a number of haemostatic variables synthesised by the liver (FII, FV, FVII and activated FVII, AT and fibrinogen) and two polymorphisms of the FVII gene (5′F7 and 353R/Q) in: (a) patients with liver cirrhosis ( n = 118), (b) patients with chronic hepatitis ( n = 102) and (c) controls ( n = 100). Results. By one-way analyses of variance, the prothrombin time and the mean levels of the FII, FV, FVIIc, FVIIa, and AT were statistically different between…